1- Beeck, A. and Dubuisson, J. (2003). Topology of hepatitis C virus envelope glycoproteins. Rev. Med. Virol. 13 (4): 233–41.
3- Gordon, S.C. ; Bayati, N. and Silverman, A.(1998). Clinical outcome of hepatitis C as a function of mode of transmission. Hepatol.; 28:562.
4- Gretch, D.R. (1997) . Diagnostic tests for hepatitis C. Hepatol.; 26 (3): 43S-47S.
5- Shev, S.; Forberg ,A. and Fryden, S.(1993). 2nd generation hepatitis C ELISA antibody tests confirmed by the 4 antigen recombinant Immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors. Vox Sang ; 65: 32-37.
6- Reddy, A.K.; Dakshinamurty, K.V. and Lakshmi, V. (2006).Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patient on heamodialysis. Ind. J. Med. Microbiol.; 24: 55-57.
7- Berry, V.; Arora, R. and Paul, P.( 2005). Hepatitis C – Clinical outcome and diagnosis. Ind. J. K. sci.; 7(1): 129-32.
8- Banker, P.D. (2003) .Viral hepatitis. Ind. J. Med. Sci.;57: 461-68.
9- Damen, M.; Zoaijer, H. and Cuyper, H. (1995) . Reliability of the third-generation recombinant Immunoblot assay for hepatitis C virus. Transf.; 35: 745-749.
10-Anne, F.; Celona, M.C. and Macnish , P. (2004) Hepatitis C in Los Angeles public hepatitis clinic: Demographic and biochemical differences associated with Race-Ethnicity. Clin. Gastroenterol. Hepatol.; 2 :459-462.
11-Sabri ,H.J.A.(2003) .The diagnostic role of liver biopsy in grading ,staging and etiology of chronic hepatitis. A thesis fellow ship Iraq commission for Medical Specialization in Pathology .
12- Douraid, K.S. (1995).Prevalence of hepatitis C virus infection in a sample of Iraqi patients with chronic liver disease. A thesis fellow ship Iraqi commission for Medical Specialization in Medicine.
13- Derek, P. ; Norah, A.; Terraul, T. (2005).Cost –effectiveness of Hepato cellular carcinoma surveillance in patients with hepatitis C virus –related cirrhosis. Clini. gastro-entero. and Hepato.;3: 75-84.
14-Rahi, S.J. (2003) .Cytokines profile in Iraqi patients infected with HCV. M. SC. Thesis, College of Medicine, University of Baghdad .
15-Moatter, T.; Hussainy, A.S.; Hamid, S.; Ahmed, Z. and Siddiqui, S. (2002). Comparative analysis of viral titers and histologic features of Pakistani patients infected with hepatitis C virus type 3. Int. J. Infect. Dis.; 6: 272-276.
16- Vandelli, C.; Renzo, F.; Braun, H.B.; Tisminetzky, S. and Albrech, M. (1999) . Prediction of successful outcome in a randomized controlled trial of the long-term efficacy of Interferon alpha treatment for chronic hepatitis C. J. Med. Vir. 58:26-34.
17- Lau, G.K.; Davis, G.L.; Wu, S.P.; Gish, R.G.; Balart, L.A. and Lau, J.Y. (1996).Hepatic Expression of hepatitis C virus RNA in chronic Hepatitis C: A study by in situ Reverse-Transcription Polymerase Chain Reaction. Heaptol .; 23(6): 1318-1323.
18- Sun, D.X.; Zhang, F.G. and Geng, Y.Q. (1996).Hepatitis C virus transmission by cosmetic tattoing in women. Lancet ; 347: 541-42.
19- Dienstag, J.L.(1991). Viral hepatitis: A mini-symposium in which recognized experts critically review clinically relevant aspects of acute and chronic. Semin. Liver Dis.; 11:23.